Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:12 AM
Ignite Modification Date:
2025-12-25 @ 1:12 AM
NCT ID:
NCT01387893
Eligibility Criteria:
Inclusion Criteria:
* mild to moderate symptoms of difficulty initiating and maintaining the flow of urine
* not currently receiving treatment for the condition
* not taking an alpha-blocker at least one month before randomization
* not taking 5-alpha reductase inhibitor six months or more before randomization.
Exclusion Criteria:
* non-ambulatory
* taking medications known to affect urination,
* any of the following: a debilitating concomitant illness, a history of prostate or bladder cancer or prostate surgery or radiation treatment to the pelvis, urethral stricture, neurogenic bladder, current urinary tract infection or otherwise potentially compromised urinary tract systems, a creatinine level of over 3.0 mg per deciliter, or a residual urinary volume after voiding of over 350 cubic centimeters.
Healthy Volunteers:
True
Sex:
MALE
Minimum Age:
45 Years
Study:
NCT01387893
Study Brief:
Protocol Section:
NCT01387893